Antivirals for Pandemic Influenza
Open Access
- 1 August 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 176 (s1) , S56-S61
- https://doi.org/10.1086/514177
Abstract
Amantadine and rimantadine share features that would make them useful agents in responding to pandemic influenza. These include an antiviral spectrumKeywords
This publication has 11 references indexed in Scilit:
- GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferretsAntimicrobial Agents and Chemotherapy, 1995
- Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homesAntimicrobial Agents and Chemotherapy, 1995
- Rimantadine: A Clinical PerspectiveAnnals of Pharmacotherapy, 1995
- Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epitheliumAntiviral Research, 1994
- Clinical and epidemiological importance of influenza a viruses resistant to amantadine and rimantadineReviews in Medical Virology, 1992
- Occurrence of Adverse Effects and High Amantadine Concentrations With Influenza Prophylaxis in the Nursing HomeJournal of the American Geriatrics Society, 1990
- Treatment of an Influenza A Outbreak in a Teaching Nursing HomeJournal of the American Geriatrics Society, 1989
- Comparison of amantadine and rimantadine for prevention of type A (Russian) influenzaAntiviral Research, 1981
- Prevention of Russian influenza by amantadineJAMA, 1979
- Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field TrialBMJ, 1970